NASDAQ
InMed Pharmaceuticals Inc. (INM) has a eps (diluted) of $-8.36 as of Monday, June 30, 2025. Diluted EPS accounts for all potential shares from stock options and convertible securities, providing a more conservative earnings-per-share measure.
No price data available for this timeframe.